A novel personalized phage therapy strategy that selects phages for a predicted evolutionary trade-off may represent a viable alternative approach for the treatment of antimicrobial-resistant bacterial infections.
- Benjamin K. Chan
- Gail L. Stanley
- Jonathan L. Koff